Inventor · disambiguated record
Masahiro Tanaka
Also filed as: TANAKA MASAHIRO
5 granted patents·7 pending applications·166 citations·filing 1990–2015
83Inventor score
Top patents by PatentIndex Score
12 records- 0194US7429596B21H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereofUNIV CALIFORNIA·Filed 2004·Granted Sep 30, 2008·104 cites·14 claims
- 0283US7244727B2Fused bicyclic nitrogen-containing heterocyclesJAPAN TOBACCO INC·Filed 2003·Granted Jul 17, 2007·22 cites·57 claims
- 0379US5214056A1,3,2-dioxathiolane oxide derivativeJAPAN TOBACCO INC·Filed 1990·Granted May 25, 1993·22 cites·23 claims
- 0478US7300932B2Pyrrolo[1,2-b]pyridazine derivativesJAPAN TOBACCO INC·Filed 2004·Granted Nov 27, 2007·14 cites·17 claims
- 0575US8017612B2Piperazine compound and use thereof as a HCV polymerase inhibitorJAPAN TOBACCO INC·Filed 2007·Granted Sep 13, 2011·4 cites·40 claims
- 0662US2009181988A1Pyrazolo Pyrimidine Derivatives and Methods of Use ThereofUNIV CALIFORNIA·Filed 2008·Application pending·0 cites
- 0759US2015031881A1Pyrazolo pyrimidine derivatives and methods of use thereofUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 0852US2016168151A1Pyrazolo pyrimidine derivatives and methods of use thereofUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
- 0952US2012065154A1Pyrazolo Pyrimidine Derivatives and Methods of Use ThereofTANAKA MASAHIRO·Filed 2011·Application pending·0 cites
- 1052US2007244096A1Fused Bicyclic Nitrogen-Containing HeterocyclesJAPAN TOBACCO INC·Filed 2007·Application pending·0 cites
- 1140US2012107273A1New piperazine compound and use thereof as a hcv polymerase inhibitorABE HIROYUKI·Filed 2011·Application pending·0 cites
- 1238US2006122181A1Heteroaromatic pentacyclic compound and medicinal use thereofJAPAN TOBACCO INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Masahiro Tanaka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →